
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder...
Attention-Deficit Hyperactivity DisorderThe main purpose of this study is to evaluate the efficacy of JNS001 titrated to daily doses of 18 to 72 mg in adults with attention-deficit hyperactivity disorder (ADHD) relative to placebo.

Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil...
Attention-deficit/Hyperactivity DisorderThis study is an open-label, 6 month trial, of immediate release methylphenidate (MPH-IR) for children with ADHD aimed at assessing whether the observable behavioral changes seen during treatment are associated with potentially more stable underlying modifications in brain functioning (resting-state functional connectivity). Additionally, we will also be looking at treatment effects on neuropsychological processes and reading skills. This information will contribute to the first Brazilian study assessing the cost-effectiveness of the treatment of ADHD. Children with ADHD will be compared to a sample of sex and age-matched sample of typically developing children.

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment...
Attention-deficit/Hyperactivity DisorderThis study is investigating the effect of sustained-release guanfacine (Intuniv) on language-based learning skills in children age 6-12 who are diagnosed with attention deficit hyperactivity disorder (ADHD).

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Pervasive Development DisordersThe purpose of this study is to determine whether guanfacine (trade name Intuniv) by itself or in combination with methylphenidate (also known as Ritalin) is helpful for treating hyperactivity in children and adolescents with a Pervasive Developmental Disorders (PDDs).

Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With...
Attention Deficit Hyperactivity DisorderDyslexiaThis study will evaluate the effects of atomoxetine on brain activation during attention and reading tasks via functional Magnetic Resonance Imaging (fMRI) in participants ages 10 to 16 years old with ADHD and comorbid dyslexia

Supplements and Social Skills Intervention Study
Conduct DisorderAttention Deficit Hyperactivity Disorder1 moreThis is a 36-week, randomised, double-blind, placebo-controlled trial. The overarching aim of this study is to assess whether a nutritional intervention (Omega-3 supplement), when combined with a more traditional treatment approach to conduct disorder and Attention Deficit Hyperactivity Disorder (ADHD), is more effective than either approach alone in treating these conditions in children and adolescents. The research questions cannot be answered through alternative means because disruptive behaviour disorders are primarily childhood disorders.

Long-Duration Stimulant Treatment Study of ADHD in Young Children
Attention Deficit Disorder With HyperactivityThis study will evaluate if Ritalin LA™ is safe and effective for ADHD treatment in 4-to-5-year olds.

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
Attention Deficit Disorder With HyperactivityThis study will evaluate the effectiveness of atomoxetine in reducing the symptoms of attention deficit hyperactivity disorder (ADHD) in young children.

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Attention Deficit Disorder With HyperactivitySubstance-Related DisordersAdolescents with attention deficit hyperactivity disorder (ADHD) often develop substance use disorders (SUD). The purpose of this study is to evaluate the effectiveness of atomoxetine in treating adolescents dually diagnosed with ADHD and SUD.

Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
AutismAttention Deficit Disorder With HyperactivityThis study examined the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) with or without additional symptoms of ADHD. The study also examined the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children with both ASD and ADHD.